Envestnet Asset Management’s Prime Medicine PRME Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-23,515
| Closed | -$46.8K | – | 4531 |
|
2025
Q1 | $46.8K | Buy |
23,515
+1,958
| +9% | +$3.9K | ﹤0.01% | 4298 |
|
2024
Q4 | $62.9K | Sell |
21,557
-6,798
| -24% | -$19.9K | ﹤0.01% | 4251 |
|
2024
Q3 | $110K | Buy |
28,355
+6,695
| +31% | +$25.9K | ﹤0.01% | 4126 |
|
2024
Q2 | $111K | Sell |
21,660
-1,220
| -5% | -$6.27K | ﹤0.01% | 4042 |
|
2024
Q1 | $160K | Buy |
22,880
+510
| +2% | +$3.57K | ﹤0.01% | 3992 |
|
2023
Q4 | $198K | Buy |
22,370
+5,754
| +35% | +$51K | ﹤0.01% | 3830 |
|
2023
Q3 | $159K | Buy |
+16,616
| New | +$159K | ﹤0.01% | 3783 |
|